Enzo Announces Issuance of U.S. Patent for Methods of Treating Liver Cancer Using Proprietary Compound SK1-I

NEXT STORY
Renibus Therapeutics Receives FDA Fast Track Designation for RBT-9 Treatment in COVID-19
PREV STORY
Next-generation Sequencing (NGS) Services Market Worth $13.1 Billion by 2025, Growing at a CAGR of 20.5% from 2019- Global Opportunity Analysis and Industry Forecasts by Meticulous Research®
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Nanobiotix revenues for the 3rd quarter of 2018

Paris, France and Cambridge, Massachusetts, USA, November 15, 2018 – NANOBIOTIX (Euronext: NANO – ...

author_avatar
NASDAQ Market News

Stereotaxis Launches Vmotion Suite of Automation Features in U.S. Following FDA Clearance

ST. LOUIS, Sept. 23, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader ...

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces First Quarter 2018 Financial Results and Business Update Conference Call on May 30

COPENHAGEN, Denmark, May 16, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company ...

author_avatar
NASDAQ Market News